title: Lack of response to imatinib mesylate as second-line therapy in a patient with c-kit positive metastatic soft tissue leiomyosarcoma.
authors.forename: Nicola
authors.initials: N
authors.lastname: Silvestris
authors.forename: Hector Soto
authors.initials: HS
authors.lastname: Parra
authors.forename: Francesco
authors.initials: F
authors.lastname: Angelini
authors.forename: Serena
authors.initials: S
authors.lastname: Di Cosimo
authors.forename: Modesto
authors.initials: M
authors.lastname: D'Aprile
authors.forename: Armando
authors.initials: A
authors.lastname: Santoro
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D000068877:Imatinib Mesylate; D007890:Leiomyosarcoma / Q000737:chemistry / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D019009:Proto-Oncogene Proteins c-kit / Q000032:analysis*; D011743:Pyrimidines / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D014408:Biomarkers, Tumor; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit